10 articles with ExeGi Pharma
The study will explore the effects of probiotics on the gut microbiota and immune systems of people living with MS.
ExeGi Wins Court Ruling Against VSL#3®*, Permanent Injunction Blocks False Advertising To Doctors, Consumers
Federal district court finds in favor of ExeGi and probiotic inventor, prohibits VSL#3 sellers from citing studies on original formulation
Trans-Atlantic study finds promising results with Visbiome Vet, a high potency probiotic, in dogs with severe form of acute diarrhea
ExeGi Pharma announced positive results from a recent study conducted at the Clinic of Small Animal Medicine at Ludwig Maximilian University (LMU) in Munich, Germany and the Department of Small Animal Clinical Sciences at Texas A&M University.
ExeGi Pharma is pleased to announce two new clinical partnerships with the College of Veterinary Medicine at the University of Georgia and the University of Tennessee to study the Visbiome Vet probiotic in domestic dogs.
Clinical studies show probiotic used to manage human GI disorders can help support bowel and gut health in dogs
ExeGi Pharma Release: Multi-Strain Probiotic May Play A Role In The Recovery Of Critical Gastrointestinal Functions In HIV-1-Positive Patients
ExeGi Pharma Release: High Concentration Probiotic May Reduce Gastrointestinal And Neurological Inflammation In HIV Patients